Current Issue

New Jersey needs turnkey lab space, faster approvals to compete for life sciences users

New Jersey needs turnkey lab space, faster approvals to compete for life sciences users

Experts say New Jersey faces a growing challenge: While it’s still a major draw for pharmaceutical research and development, speed to market has become increasingly important to life sciences users. That means the state’s lack of move-in-ready lab space — and its lengthy approval process for new construction — puts it at a disadvantage to competing markets.

read more